Bio Protocol Raises 6.9m Seed Round Led By Maelstrom Fund

Key Takeaways

Bio Protocol secured 6.9 million in seed funding led by Arthur Hayes Maelstrom Fund, with participation from major venture firms.

The DeSci platform allows scientists to create decentralised AI agents BioAgents to accelerate research and attract funding.

The new capital will expand Bio V2, a platform upgrade introducing Ignition Sales, staking, and the BioXP rewards programme.

Decentralised science protocol Bio has raised 6.9 million in a seed round led by Arthur Hayes Maelstrom Fund, with backing from Mechanism Capital, Animoca Brands, Zee Prime Capital, Panga Capital, Mirana Ventures, Foresight Ventures, Big Brain Holdings, and others.

The announcement follows the launch of Bio V2, the protocols upgraded platform designed to build an onchain scientific superintelligence.